Page last updated: 2024-11-02

pioglitazone and Cancer of the Retina

pioglitazone has been researched along with Cancer of the Retina in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"We aimed to study the antitumor effects of the PPARγ agonist pioglitazone on human retinoblastoma."7.85Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals. ( Bi, Z; Liu, Y; Wang, F, 2017)
"We aimed to study the antitumor effects of the PPARγ agonist pioglitazone on human retinoblastoma."3.85Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals. ( Bi, Z; Liu, Y; Wang, F, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, F1
Liu, Y1
Bi, Z1

Other Studies

1 other study available for pioglitazone and Cancer of the Retina

ArticleYear
Pioglitazone inhibits growth of human retinoblastoma cells via regulation of NF-κB inflammation signals.
    Journal of receptor and signal transduction research, 2017, Volume: 37, Issue:1

    Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Gene Expression Regulation, Neoplastic; H

2017